Pharmacy Practice Pharmacy Workforce

ASHP Commission Examines Data-Driven Healthcare

Kate Traynor
Kate Traynor Senior Writer, ASHP News Center Published: March 9, 2023

The management of digital health technology for better patient care was on the agenda at the March 7 meeting of ASHP’s Commission on Goals, whose members offered strategic guidance on optimizing medication use through advanced analytics and data-driven healthcare.

The interdisciplinary commission meets annually to provide critical guidance for the ASHP Board of Directors and to help shape ASHP’s strategic direction.

This year’s commission roster included leaders in pharmacy, medicine, nursing, digital health technology, public health, industry, and government.

The group was asked to provide guidance on four main topics:

  • Establishing organizational priorities on data collection and use
  • The interface of digital health, data science, and medication use
  • Organizational structures and workforce preparation to leverage data for comprehensive medication management
  • Optimization and protection of medication-use data


Commission members described having access to prescribing and dispensing information as well as data from electronic medical records, automated dispensing cabinets, infusion pumps, robotics, wearable devices, and many other sources.

During the session on data prioritization, meeting participants discussed the need to establish policies and processes to ensure data security and protect patient privacy; uncertainty about the clinical and financial value of investments in technology; usability of data by clinicians; how to leverage data to improve health equity; and how to effectively allocate staff resources to manage data prioritization and use.

Some organizations are meeting these concerns, in part, by establishing health data governance and stewardship groups to ensure that data-use decisions align with the institution’s mission and values, according to meeting participants.

The session on the interface of digital health, data science, and medication use focused largely on the benefits and limits of artificial intelligence (AI) models in healthcare. Participants sought clarity on how to evaluate AI models, when to trust or question their recommendations, and how to work collaboratively on care teams to promote AI models that improve the efficiency and quality of care.

During the session on workforce preparation, commission members agreed on the need to ensure competence in informatics in a healthcare environment that’s short on specialists in the field. The group emphasized the need for lifelong learning in technology and data science and suggested collaborating with medicine and nursing colleagues to establish shared competencies in informatics that reinforce team-based care.

The session on protecting medication-use data featured remarks from attendees who described the aftermath of ransomware attacks. Participants said the events underscored the need to train all staff on preventing illicit access to data systems. Commission members also discussed privacy challenges related to data security and the need to establish pharmacy’s place in cybersecurity initiatives.

During the final round of discussions, commission members shared their views on data trends and opportunities that may affect the medication use and pharmacy practice in the next 3–5 years. Participants predicted an increase in reliance on pharmacogenomics, social determinants of health, and AI to inform decision-making and push towards virtual care. Group members also speculated that advances in AI and robotics could help alleviate the effects of workforce shortages, freeing clinicians to focus on direct patient care activities.

“This meeting is very timely,” said commission chair and ASHP Past President Thomas J. Johnson during a break in the sessions. “I know from my own experience, and from talking with colleagues across the country, that the use and management of data is a top priority but also a significant challenge for many health systems. Our discussions today will help ASHP develop priorities to support our members and the healthcare system as we optimize the use of data to improve medication management for our patients.”

Proceedings of the commission’s meeting will be published in AJHP.

Commission Members

Thomas Johnson Chair North Dakota
Linda Tyler Vice Chair Utah
Paul Abramowitz   Maryland
Amanda Brummel   Minnesota
Rich Caruana   Washington
Kathy Chappell   Maryland
Micah Cost   Tennessee
Christopher Hatwig   Texas
Todd Henderson   Kansas
John Komenda   Wisconsin
Tom Leary   Virginia
Patsy McNeil   Maryland
Stephen Mullenix   Colorado
Parth Patel   Massachusetts
Ken Perez   California
Chris Rochon   New Hampshire
Scott Rochowiak   Minnesota
Shannon Sims   Illinois
Lisa Stump   Connecticut
Sara Van Driest   Tennessee
Kasey Thompson Secretary Maryland
Posted March 9, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information